Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1324 (RO 40-7592, RO-40-7592, RO-407592, Tasmar, Tolcapona, Tolcapone) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ABCB11/Bile salt export pump in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073674] [GtoPdb: 778] [UniProtKB: O70127] | ||||||||
ChEMBL | Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 4.33 | pIC50 | 47200 | nM | IC50 | Drug Metab Dispos (2012) 40: 130-138 [PMID:21965623] |
Catechol-O-methyltransferase/Catechol O-methyltransferase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2023] [GtoPdb: 2472] [UniProtKB: P21964] | ||||||||
GtoPdb | membrane-bound enzyme | - | 9.54 | pKi | 0.29 | nM | Ki | Biochemistry (1995) 34: 4202-10 [PMID:7703232] |
GtoPdb | soluble enzyme | - | 9.57 | pKi | 0.27 | nM | Ki | Biochemistry (1995) 34: 4202-10 [PMID:7703232] |
ChEMBL | Inhibition of human recombinant His-tagged soluble COMT expressed in Escherichia coli BL21 using aesculetin as substrate after 60 mins by microplate assay in presence of SAM | B | 6.9 | pIC50 | 127 | nM | IC50 | J Med Chem (2016) 59: 4664-4675 [PMID:27074629] |
ChEMBL | Inhibition of c-terminal hexa-His tagged human MB-COMT (unknown origin) | B | 9 | pIC50 | <1 | nM | IC50 | J Med Chem (2018) 61: 9647-9665 [PMID:30272964] |
ChEMBL | Inhibition of human MB-COMT expressed in HEK293 cells using dopamine as substrate and SAM as cofactor preincubated for 30 mins followed by substrate addition and measured after 40 mins by HTRF assay | B | 9 | pIC50 | <1 | nM | IC50 | ACS Med Chem Lett (2019) 10: 1573-1578 [PMID:32038769] |
Catechol-O-methyltransferase/Catechol O-methyltransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2372] [GtoPdb: 2472] [UniProtKB: P22734] | ||||||||
ChEMBL | Inhibitory activity against COMT in rat brain | B | 5.66 | pIC50 | 2200 | nM | IC50 | J Med Chem (2005) 48: 8070-8078 [PMID:16335931] |
ChEMBL | Inhibitory activity against COMT in rat liver | B | 6.03 | pIC50 | 930 | nM | IC50 | J Med Chem (2005) 48: 8070-8078 [PMID:16335931] |
ChEMBL | Inhibition of S-COMT in rat liver homogenates using adrenaline as substrate and SAM as cofactor preincubated for 20 mins followed by substrate addition and measured after 5 mins | B | 7.28 | pIC50 | 53 | nM | IC50 | Eur J Med Chem (2022) 243: 114740-114740 [PMID:36116233] |
ChEMBL | Inhibition of S-COMT in Wistar rat liver assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 5 mins by chromatographic analysis | B | 7.51 | pIC50 | 30.59 | nM | IC50 | J Med Chem (2016) 59: 7584-7597 [PMID:27463695] |
ChEMBL | Inhibition of MB-COMT in rat liver homogenates using adrenaline as substrate and SAM as cofactor preincubated for 20 mins followed by substrate addition and measured after 5 mins | B | 7.77 | pIC50 | 17 | nM | IC50 | Eur J Med Chem (2022) 243: 114740-114740 [PMID:36116233] |
ChEMBL | Inhibition of MB-COMT in rat brain homogenates using adrenaline as substrate and SAM as cofactor preincubated for 20 mins followed by substrate addition and measured after 5 mins | B | 8.52 | pIC50 | 3 | nM | IC50 | Eur J Med Chem (2022) 243: 114740-114740 [PMID:36116233] |
ChEMBL | Inhibition of rat COMT | B | 8.66 | pIC50 | 2.2 | nM | IC50 | Bioorg Med Chem (2016) 24: 1419-1430 [PMID:26935940] |
ChEMBL | Inhibition of Catechol O-methyltransferase activity in rat brain | B | 8.66 | pIC50 | 2.2 | nM | IC50 | J Med Chem (2002) 45: 685-695 [PMID:11806720] |
ChEMBL | Inhibition of MB-COMT in Wistar rat brain assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 15 mins by chromatographic analysis | B | 9.04 | pIC50 | 0.91 | nM | IC50 | J Med Chem (2016) 59: 7584-7597 [PMID:27463695] |
ChEMBL | Inhibition of MB-COMT in Wistar rat brain assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 15 mins by chromatographic analysis | B | 9.04 | pIC50 | 0.91 | nM | IC50 | J Med Chem (2016) 59: 7584-7597 [PMID:27463695] |
Dengue virus type 2 NS3 protein in Dengue virus type 2 (strain Thailand/16681/1984) (DENV-2) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5980] [UniProtKB: P29990] | ||||||||
ChEMBL | Inhibition of DENV2 NS2B-NS3 serine protease expressed using Benzoyl-Nle-Lys-Arg-Arg-AMC as substrate measured preincubated for 3 mins followed by substrate addition by fluorescence assay | B | 6.19 | pIC50 | 640 | nM | IC50 | Eur J Med Chem (2019) 176: 431-455 [PMID:31128447] |
ChEMBL | Inhibition of Dengue Virus 1 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins | B | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454] |
ChEMBL | Inhibition of Dengue Virus 2 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins | B | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454] |
ChEMBL | Inhibition of Dengue Virus 3 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins | B | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454] |
ChEMBL | Inhibition of Dengue Virus 4 recombinant NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Arg-Arg-AMC as substrate incubated for 30 mins | B | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem (2021) 49: 116415-116415 [PMID:34601454] |
ChEMBL | Inhibition of NS2B-NS3 protease in DENV2proHeLa system assessed as inhibition of luciferase signal incubated for 24 hrs by luciferase reporter gene assay | B | 5.15 | pEC50 | 7100 | nM | EC50 | J Med Chem (2021) 64: 4567-4587 [PMID:33851839] |
Genome polyprotein in West Nile virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5419] [UniProtKB: P06935] | ||||||||
ChEMBL | Inhibition of West Nile virus NS2B-NS3 protease expressed in Escherichia coli using Bz-Nle-Lys-Arg-Arg-AMC as substrate assessed as proteolytic activity by monochrometer-based spectrofluorometeric analysis | B | 6.15 | pIC50 | 700 | nM | IC50 | RSC Med Chem (2021) 12: 1262-1272 [PMID:34458734] |
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97] | ||||||||
ChEMBL | Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay | B | 4.31 | pEC50 | 49200 | nM | EC50 | Medchemcomm (2012) 3: 1270-1274 |
ChEMBL | Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis | B | 5.13 | pEC50 | 7440 | nM | EC50 | Medchemcomm (2012) 3: 1270-1274 |
Krueppel-like factor 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3407312] [UniProtKB: Q13118] | ||||||||
ChEMBL | Inhibition of human KLF10 expressed in human HeLa cells assessed as reduction in transcriptional activity after 24 hrs by CACCC-responsive promoter driven TK-luciferase reporter gene assay | B | 4.3 | pIC50 | 50000 | nM | IC50 | J Med Chem (2015) 58: 1466-1478 [PMID:25581017] |
ChEMBL | Inhibition of human KLF10 expressed in human HeLa cells assessed as reduction in KLF10-mediated transcriptional activity incubated for 24 hrs by luciferase reporter assay | B | 4.3 | pIC50 | 50000 | nM | IC50 | US-20170121318-A1. Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy (2017) |
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] | ||||||||
ChEMBL | Binding affinity to TTR V30M mutant (unknown origin) expressed in Escherichia coli incubated for 60 mins by tryptophan intrinsic fluorescence method | B | 6.01 | pKd | 980 | nM | Kd | J Med Chem (2021) 64: 14344-14357 [PMID:34547896] |
ChEMBL | Binding affinity to TTR V30M mutant (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by ITC analysis | B | 6.36 | pKd | 440 | nM | Kd | Eur J Med Chem (2023) 261: 115837-115837 [PMID:37837673] |
ChEMBL | Binding affinity to TTR V30M mutant (unknown origin) by isothermal titration calorimetry | B | 7.02 | pKd | 95 | nM | Kd | J Med Chem (2021) 64: 14344-14357 [PMID:34547896] |
ChEMBL | Binding affinity to transthyretin V122I mutant (unknown origin) by ITC method | B | 7.25 | pKd | 56 | nM | Kd | J Med Chem (2018) 61: 7862-7876 [PMID:30133284] |
ChEMBL | Binding affinity to TTR V122I mutant (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by ITC analysis | B | 7.3 | pKd | 50 | nM | Kd | Eur J Med Chem (2023) 261: 115837-115837 [PMID:37837673] |
ChEMBL | Binding affinity to wild-type TTR (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as dissociation constant by ITC analysis | B | 7.32 | pKd | 48 | nM | Kd | Eur J Med Chem (2023) 261: 115837-115837 [PMID:37837673] |
ChEMBL | Binding affinity to wild type TTR (unknown origin) assessed as dissociation constant by ITC assay | B | 7.47 | pKd | 34 | nM | Kd | J Med Chem (2022) 65: 14673-14691 [PMID:36306808] |
ChEMBL | Binding affinity to wild type TTR (unknown origin) assessed as gibbs free energy change by ITC analysis | B | 7.47 | pKd | 34 | nM | Kd | J Med Chem (2022) 65: 14673-14691 [PMID:36306808] |
ChEMBL | Binding affinity to transthyretin (unknown origin) by ITC method | B | 7.69 | pKd | 20.6 | nM | Kd | J Med Chem (2018) 61: 7862-7876 [PMID:30133284] |
ChEMBL | Stabilization of wild type TTR (unknown origin) expressed in Escherichia coli assessed as reduction in methanol-induced aggregation incubated for 60 min by absorbance method | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (2021) 64: 14344-14357 [PMID:34547896] |
ChEMBL | Stabilization of TTR V30M mutant (unknown origin) assessed as acid-mediated protein aggregation inhibition ratio incubated for 1 week by absorbance method | B | 5.49 | pIC50 | 3200 | nM | IC50 | J Med Chem (2021) 64: 14344-14357 [PMID:34547896] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]